» Articles » PMID: 29098473

Synthesis, Characterization and in Vitro Antimicrobial Activity of Novel Fused Pyrazolo[3,4-c]pyridazine, Pyrazolo[3,4-d]pyrimidine, Thieno[3,2-c]pyrazole and Pyrazolo[3',4':4,5]thieno[2,3-d]pyrimidine Derivatives

Overview
Journal Chem Cent J
Publisher Biomed Central
Specialty Chemistry
Date 2017 Nov 4
PMID 29098473
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Some novel substituted pyrazolone, pyrazolo[3,4-c]pyridazine, pyrazolo[3,4-d]pyrimidine, pyrazolo[3,4-d]thiazolo[3,2-a]pyrimidinone, thieno[3,2-c]pyrazole and pyrazolo[3',4':4,5]thieno[2,3-d]pyrimidine derivatives have been reported to possess various pharmacological activities like antimicrobial, antitumor and anti-inflammatory.

Results: A novel series of azoles and azines were designed and prepared via reaction of 1,3-diphenyl-1H-pyrazol-5(4H)-one with some electrophilic and nucleophilic reagents. The structures of target compounds were confirmed by elemental analyses and spectral data.

Conclusions: The antimicrobial activity of the target synthesized compounds were tested against various microorganisms such as Escherichia coli; Bacillus megaterium; Bacillus subtilis (Bacterial species), Fusarium proliferatum; Trichoderma harzianum; Aspergillus niger (fungal species) by the disc diffusion method. In general, the novel synthesized compounds showed a good antimicrobial activity against the previously mentioned microorganisms.

Citing Articles

New 1,3-diphenyl-1-pyrazol-5-ols as anti-methicillin resistant agents: Synthesis, antimicrobial evaluation and studies.

Reheim M, Abdel Hafiz I, Reffat H, Abdel Rady H, Shehadi I, Rashdan H Heliyon. 2024; 10(13):e33160.

PMID: 39035494 PMC: 11259802. DOI: 10.1016/j.heliyon.2024.e33160.


Antiviral Effect and Mechanism of Edaravone against Grouper Iridovirus Infection.

Kuang J, Liu M, Yu Q, Cheng Y, Huang J, Han S Viruses. 2023; 15(11).

PMID: 38005914 PMC: 10674758. DOI: 10.3390/v15112237.


The inhibitory effect of some pyrazole ligands and their Cu(II) complexes on the growth of spp., and .

Zaimovic M, Kosovic Perutovic M, Jelusic G, Radovic A, Jacimovic Z Front Pharmacol. 2022; 13:921157.

PMID: 36059995 PMC: 9428121. DOI: 10.3389/fphar.2022.921157.


Antibacterial pyrazoles: tackling resistant bacteria.

Alam M Future Med Chem. 2022; 14(5):343-362.

PMID: 35050719 PMC: 8890142. DOI: 10.4155/fmc-2021-0275.


Inhibition of Glioma Cell Growth and Apoptosis Induction through Targeting Wnt10B Expression by Pyrazolo[4,3-c]pyridine-4-one.

Liu Y, Yaozu Z, Zhao H, Peng P, Tingbao Z, Jincao C Med Sci Monit. 2020; 26:e923912.

PMID: 33173023 PMC: 7670829. DOI: 10.12659/MSM.923912.


References
1.
Manojkumar P, Ravi T, Gopalakrishnan S . Antioxidant and antibacterial studies of arylazopyrazoles and arylhydrazonopyrazolones containing coumarin moiety. Eur J Med Chem. 2009; 44(11):4690-4. DOI: 10.1016/j.ejmech.2009.07.004. View

2.
Mohamed M, Kamel M, Kassem E, Abotaleb N, Nofal S, Ahmed M . Novel 3-(p-substituted phenyl)-6-bromo-4(3H)-quinazolinone derivatives of promising antiinflammatory and analgesic properties. Acta Pol Pharm. 2009; 66(5):487-500. View

3.
Bekhit A, Abdel-Aziem T . Design, synthesis and biological evaluation of some pyrazole derivatives as anti-inflammatory-antimicrobial agents. Bioorg Med Chem. 2004; 12(8):1935-45. DOI: 10.1016/j.bmc.2004.01.037. View

4.
Bondock S, Rabie R, Etman H, Fadda A . Synthesis and antimicrobial activity of some new heterocycles incorporating antipyrine moiety. Eur J Med Chem. 2008; 43(10):2122-9. DOI: 10.1016/j.ejmech.2007.12.009. View

5.
Mosaad M, Mohsen K, Emad K, Abotaleb N, Salwa N, Marwa A . Novel 6,8-dibromo-4(3H)-quinazolinone derivatives of promising anti-inflammatory and analgesic properties. Acta Pol Pharm. 2010; 67(2):159-71. View